Aurinia

Aurinia Pharmaceuticals is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. In January 2021, Aurinia introduced LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. Aurinia is also developing aritinercept, a dual inhibitor of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) for the potential treatment of autoimmune diseases. The company's corporate headquarters is located in Edmonton, Alberta, Canada, with a United States office in Rockville, Maryland.

Aurinia Pharmaceuticals is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. In January 2021, Aurinia introduced LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. Aurinia is also developing aritinercept, a dual inhibitor of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) for the potential treatment of autoimmune diseases.

• 2026.10.30

  Reported2026.11.01

  Aurinia raises 2026 revenue guidance[3]Aurinia上调2026年收入指引dailypolitical.com

  Aurinia raised its 2026 total revenue guidance to $325 million to $330 million from $315 million to $325 million, and lifted the low end of its net product sales guidance to $310 million from $305 million.

• 2019.11.14

  Reported2019.11.14

  Aurinia reports third-quarter 2019 financial results[4]Aurinia公布2019年第三季度财务业绩financialpost.com

  Aurinia reported financial results for the three and nine months ended September 30, 2019, including a consolidated net loss of $19.0 million for the third quarter.

Read more

1. 1Our Company | Aurinia Pharmaceuticals Inc. (AUPH)auriniapharma.com
2. 2Contact Us | Aurinia Pharmaceuticals Inc. (AUPH)auriniapharma.com
3. 3Aurinia上调2026年收入指引dailypolitical.com
4. 4Aurinia公布2019年第三季度财务业绩financialpost.com
5. 5Aurinia Reports First Quarter 2020 Financial Results and Recent Operational Highlightsfinancialpost.com
6. 6Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlightsinvestingnews.com
7. 7Aurinia Reports Third Quarter 2019 Financial Results and Recent Operational Highlightsbiospace.com